| Literature DB >> 33797634 |
Scott Monteith1, Tasha Glenn2, John Geddes3, Emanuel Severus4, Peter C Whybrow5, Michael Bauer6.
Abstract
BACKGROUND: Internet of Things (IoT) devices for remote monitoring, diagnosis, and treatment are widely viewed as an important future direction for medicine, including for bipolar disorder and other mental illness. The number of smart, connected devices is expanding rapidly. IoT devices are being introduced in all aspects of everyday life, including devices in the home and wearables on the body. IoT devices are increasingly used in psychiatric research, and in the future may help to detect emotional reactions, mood states, stress, and cognitive abilities. This narrative review discusses some of the important fundamental issues related to the rapid growth of IoT devices. MAIN BODY: Articles were searched between December 2019 and February 2020. Topics discussed include background on the growth of IoT, the security, safety and privacy issues related to IoT devices, and the new roles in the IoT economy for manufacturers, patients, and healthcare organizations.Entities:
Keywords: Bipolar disorder; Internet of things; Privacy; Psychiatry; Security
Year: 2021 PMID: 33797634 PMCID: PMC8018992 DOI: 10.1186/s40345-020-00216-y
Source DB: PubMed Journal: Int J Bipolar Disord ISSN: 2194-7511
Examples of IoT devices
| Home devices: |
| Automobile systems |
| Bathroom appliances |
| Door and window locks |
| Kitchen appliances (refrigerators, stoves) |
| Lighting |
| Security cameras |
| Smoke alarms |
| Speakers |
| Thermostats |
| Toys |
| TVs |
| Utility meters |
| Vacuum cleaners |
| Voice assistants |
| Consumer health/medical devices: |
| Baby clothes that monitor respiration |
| Electronic pill bottles |
| Environmental chemical sensors |
| Fitness trackers |
| Football helmets that analyze impacts |
| Scales |
| Sleep monitors |
| Smart toothbrush |
| Thermometers |
| Video games to improve attention |
| Voice assistants to refill prescriptions |
| Water bottles |
| Wearable blood pressure monitors |
| Wearable ECG monitors |
| Wearable sweat sensors |
| Approved medical devices from physicians: |
| Cardiac implanted devices (pacemakers, defibrillators) |
| Cochlear implant |
| Drug delivery systems |
| Foot drop implants |
| Glucose monitors |
| Implanted biosensors |
| Ingestible medications |
| Neurostimulators |
| Oxygen saturation |
| Patient identification and tracking |
| Smart inhalers |
| Vital sign monitors |
Example studies of patients with bipolar disorder using data from IoT devices (wearable devices and ingestible sensors)
| Study | IoT device | Measure | Participants | Study aim |
|---|---|---|---|---|
| Tanaka (2018) | Wrist-worn accelerometer | Physical activity | 94 inpatients: 57 with MDD; 35 BP with depression.* | Distinguish activity patterns between adults with BP and MDD |
| Faedda (2016) | Wrist-worn accelerometer | Physical activity | 155 youths: 48 with BP, 44 with ADHD; 21 with ADHD + MDD; 42 controls | Distinguish children with BP from those with ADHD and healthy controls |
| McGowan (2020) | Wrist-worn accelerometer | Physical activity | 87 patients: 31 with BP; 21 with BPD; 35 healthy controls | Compare rest-activity patterns in those with BP, BPD, and healthy controls |
| Merikangas (2019) | Wrist-worn accelerometer | Physical activity | 242 adults: 54 with BP; 91 with MDD; 97 healthy controls | Compare associations between activity, sleep, energy and mood in those with and without mood disorders |
| Rodríguez-Ruiz (2020) | Wrist-worn accelerometer | Physical activity | 55 patients: 23 with BP or MDD; 32 healthy controls | Compare activity in the day and night to classify depressive episodes |
| Janney (2014) | Elasticized belt containing an accelerometer | Physical activity | 60 patients: 41 with BPI, 17 with BPII; 2 with BP NOS | Understand the physical activity and sedentary behavior of adults with BP |
| Kappeler-Setz (2013) | Socks with sensor of skin conductance | Electrodermal activity (changes in sweat gland activity) | Eight healthy subjects; feasibility study | Use for long-term monitoring of patients with BP |
| Valenza (2014) | T-shirt embedded with electrodes and sensors | ECG | Eight patients with BP | Predict mood states from heart rate variability in patients with BP |
| Nardelli (2017) | T-shirt embedded with electrodes and sensors | ECG | Eight patients; six with BPI; 2 with BPII | Study of diurnal and nocturnal heartbeat dynamics in BP mood states |
| Gentili (2017) | T-shirt embedded with electrodes and sensors | ECG | Eight patients with BP | Predict mood changes from heart rate dynamics in patients with BP |
| Kopelowicz (2017) | Ingestible sensor in tablets | Ingestion of Abilify MyCite (aripiprazole) | 49 patients; 22 with BPI; 15 with schizophrenia; 12 with MDD | Implement a call center to facilitate adherence monitoring of patients using a digital pill system |
*BP bipolar disorder, MDD major depressive disorder, ADHD attention deficit/hyperactivity disorder, BPD borderline personality disorder